These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1815 related items for PubMed ID: 35508320

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. PCSK9 inhibitors and ezetimibe with or without statin therapy for cardiovascular risk reduction: a systematic review and network meta-analysis.
    Khan SU, Yedlapati SH, Lone AN, Hao Q, Guyatt G, Delvaux N, Bekkering GET, Vandvik PO, Riaz IB, Li S, Aertgeerts B, Rodondi N.
    BMJ; 2022 May 04; 377():e069116. PubMed ID: 35508321
    [Abstract] [Full Text] [Related]

  • 3. Sodium-glucose cotransporter-2 (SGLT-2) inhibitors for adults with chronic kidney disease: a clinical practice guideline.
    Agarwal A, Zeng X, Li S, Rayner D, Foroutan F, Aertgeerts B, Coyac F, Farhoumand PD, Demaine A, Heen AF, Jha V, Machuve E, Nagler E, Tunnicliffe DJ, Guyatt GH, Vandvik PO, Ponte B, Agoritsas T.
    BMJ; 2024 Oct 01; 387():e080257. PubMed ID: 39353639
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. SGLT-2 inhibitors or GLP-1 receptor agonists for adults with type 2 diabetes: a clinical practice guideline.
    Li S, Vandvik PO, Lytvyn L, Guyatt GH, Palmer SC, Rodriguez-Gutierrez R, Foroutan F, Agoritsas T, Siemieniuk RAC, Walsh M, Frere L, Tunnicliffe DJ, Nagler EV, Manja V, Åsvold BO, Jha V, Vermandere M, Gariani K, Zhao Q, Ren Y, Cartwright EJ, Gee P, Wickes A, Ferns L, Wright R, Li L, Hao Q, Mustafa RA.
    BMJ; 2021 May 11; 373():n1091. PubMed ID: 33975892
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Lipid-lowering treatment up to one year after acute coronary syndrome: guidance from a French expert panel for the implementation of guidelines in practice.
    Sabouret P, Puymirat E, Kownator S, Abdennbi K, Lebeau F, Meltz M, Angoulvant D, Schiele F.
    Panminerva Med; 2023 Jun 11; 65(2):244-249. PubMed ID: 36222543
    [Abstract] [Full Text] [Related]

  • 11. Benefits and drawbacks of statins and non-statin lipid lowering agents in carotid artery disease.
    Paraskevas KI, Gloviczki P, Antignani PL, Comerota AJ, Dardik A, Davies AH, Eckstein HH, Faggioli G, Fernandes E Fernandes J, Fraedrich G, Geroulakos G, Golledge J, Gupta A, Gurevich VS, Jawien A, Jezovnik MK, Kakkos SK, Knoflach M, Lanza G, Liapis CD, Loftus IM, Mansilha A, Nicolaides AN, Pini R, Poredos P, Proczka RM, Ricco JB, Rundek T, Saba L, Schlachetzki F, Silvestrini M, Spinelli F, Stilo F, Suri JS, Svetlikov AV, Zeebregts CJ, Chaturvedi S, Veith FJ, Mikhailidis DP.
    Prog Cardiovasc Dis; 2022 Jun 11; 73():41-47. PubMed ID: 35605696
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The therapeutic management of South African dyslipidaemic patients at very high cardiovascular risk (CARDIO TRACK): a cross-sectional study.
    Blom DJ, Ranjith N, Joshi P, Naidoo P, van Tonder A, Musa MG, Joshi S, Leisegang R, Trokis JS, Makan H, Raal FJ.
    Cardiovasc J Afr; 2020 Jun 11; 31(5):245-251. PubMed ID: 33151240
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 91.